Cleared Traditional

K812314 - CRITHIDNA ANTI-DNA TEST KIT

K812314 is an FDA 510(k) clearance for CRITHIDNA ANTI-DNA TEST KIT, manufactured by Antibodies, Inc.. The device is a Class 2 Immunology device with product code DHN cleared through the Traditional 510(k) pathway after a 15-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1981
Decision
15d
Days
Class 2
Risk

K812314 is an FDA 510(k) clearance for the CRITHIDNA ANTI-DNA TEST KIT. Classified as Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control (product code DHN), Class II - Special Controls.

Submitted by Antibodies, Inc. (Mchenry, US). The FDA issued a Cleared decision on September 1, 1981 after a review of 15 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5100 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K812314

510(k) Number K812314 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 17, 1981
Decision Date September 01, 1981
Days to Decision 15 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
90d faster than avg
Panel avg: 105d · This submission: 15d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DHN Device Classification - Class 2, Special Controls

Product Code DHN Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DHN Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control

All 109
Devices cleared under the same product code (DHN) and FDA review panel - the closest regulatory comparables to K812314.
ANTINUCLEAR ANTOBODY CELL SUBSTRATE
K822607 · Immulok, Inc. · Sep 1982
ANA TEST (MOUSE LIVER SUBSTRATE)
K820265 · Meloy Laboratories, Inc. · Feb 1982
QUANTAFLUOR FLUORESCENT TEST REAGENTS
K813592 · Kallestad Laboratories, Inc. · Jan 1982
HEP-2-CRITHIDIA LUCILIAE ANA TEST KIT
K811714 · Scripps-Miles, Inc. · Jul 1981
ANTINUCLEAR ANTIBODY IMMUNOFLUORESCENT
K810985 · Immuno-Products Industries · May 1981
ANA TEST KIT
K811022 · Immuno-Diagnostic Products, Inc. · Apr 1981